Prasol Chemicals IPO GMP Today and Kostak Price
Prasol Chemicals IPO Grey Market Premium (GMP) today stands at ₹ 14, showing mild but stable interest in the grey market ahead of listing. The Kostak rate is currently not available, while the Subject to Sauda price is quoted at currently not available. On 3 September 2026, the IPO GMP recorded a high of ₹14 and a low of ₹14 on 3 September 2026, indicating steady grey market activity. You can check the day-wise GMP trend below to track price movement and investor sentiment over time.
Prasol Chemicals IPO is scheduled to open for subscription on September 8, 2026. The public issue aims to raise around ₹500 Cr. and is offered in a price band of ₹643 to ₹676 per share, with a market lot of 22 shares. Investors are closely watching subscription data and grey market trends ahead of the listing.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 03 Sep 2026 | ₹ 14 | 2.07% | ₹ 0 | ₹ 0 |
Prasol Chemicals IPO Dates
| Event | Date |
|---|---|
| Open Date | 08 Sep, 2026 |
| Close Date | 10 Sep, 2026 |
| Allotment Date | 11 Sep, 2026 |
| Refund Date | 15 Sep, 2026 |
| Credit to Demat | 15 Sep, 2026 |
| Listing Date | 16 Sep, 2026 |
Prasol Chemicals IPO Expected Listing Price
| Basis | Value |
|---|---|
| Issue Price (Upper Band) | ₹676 |
| Current GMP | ₹ 14 |
| GMP-Based Listing Estimate | ₹690 (+2.1%) |
| Listing Date | 16 Sep, 2026 |
Disclaimer: The listing price estimate above is based purely on the current grey market premium (GMP) and is not a guaranteed prediction. GMP is an unofficial, unregulated indicator and can change significantly in the 24–48 hours before listing. Do not make investment decisions based solely on GMP.
Is Prasol Chemicals IPO GMP Reliable?
Grey market premium for Prasol Chemicals IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Prasol Chemicals IPO full review for a fundamentals-based assessment before making any grey market trades.
Prasol Chemicals IPO IPO Kostak Rate Explained
The Kostak rate for Prasol Chemicals IPO is currently not active. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price has not been quoted yet. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Prasol Chemicals IPO
The company makes more than 150 different specialty chemicals. Its range covers 21 acetone based chemicals, 53 phosphorous based chemicals and 76 other products such as surfactants, esters and acids.
These products go into five main industries. These are performance chemicals such as lubricant and mining additives, the group known as PICA which covers paint, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care. Its customers include Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience and Yasho Industries. As on 31 July 2026 it served about 1,600 customers and exported to 69 countries, and it is certified as a 3 Star Export House by the Government of India. It runs two plants, at Khopoli covering 1,20,604 square metres and at Mahad covering 1,19,423 square metres, with a combined capacity of 98,644 tonnes a year.
Strengths & Risks
Strengths
- ✓ Profit has grown more than four times in two years, from Rs 18.13 crore in FY2024 to Rs 43.57 crore in FY2025 and Rs 83.12 crore in FY2026.
- ✓ Sales have grown steadily, from Rs 887.56 crore in FY2024 to Rs 1,015.54 crore in FY2025 and Rs 1,237.85 crore in FY2026.
- ✓ EBITDA more than doubled over the same period, from Rs 60.53 crore to Rs 139.32 crore.
- ✓ The product range is very wide at more than 150 chemicals, spread across five different end industries, so it does not depend on one sector.
- ✓ The customer base is large and reputed, with about 1,600 customers including Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science and Croda India.
- ✓ It exports to 69 countries and is certified as a 3 Star Export House, with distribution across Asia Pacific, the Americas and Europe.
- ✓ It has a long record of more than 30 years and two plants with a combined capacity of 98,644 tonnes a year.
- ✓ RoCE was 22.43% and RoNW was 18.53% in FY2026.
Risks
- ⚠ The P/E and EPS are not stated in the data available to us, so the issue cannot be compared with chemical peers on earnings from here.
- ⚠ The profit margin is thin at 6.74%, which is low for a company describing itself as a specialty chemicals maker.
- ⚠ Very little of the money is going into the business. Only Rs 60 crore of the Rs 500 crore issue is earmarked for repaying borrowings, with the rest to general corporate purposes and to the selling shareholders.
- ⚠ Borrowing has gone up every year, from Rs 82.07 crore in FY2024 to Rs 101.05 crore in FY2025 and Rs 110.06 crore in FY2026.
- ⚠ Raw material prices drive this business. Acetone and phosphorus feedstock are linked to crude and to global chemical cycles, and a sharp rise cannot always be passed on.
- ⚠ Both plants are in Maharashtra, at Khopoli and Mahad, so there is regional concentration, and chemical plants carry pollution control and environmental compliance risk.
- ⚠ Exporting to 69 countries brings currency risk and exposure to anti-dumping duties and trade rules in those markets.
- ⚠ This is a fresh issue combined with an offer for sale, and promoter holding falls from 89.2% to 77.51% after the issue.
Frequently Asked Questions about Prasol Chemicals IPO
What is the GMP of Prasol Chemicals IPO?
The current Grey Market Premium (GMP) of Prasol Chemicals IPO is ₹ 14.
What is the Kostak Price of Prasol Chemicals IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Prasol Chemicals IPO is currently not available.
What is the Subject to Sauda Price of Prasol Chemicals IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.
What is the expected listing price of Prasol Chemicals IPO based on GMP?
Based on the current GMP of ₹ 14, Prasol Chemicals IPO is expected to list around ₹690 — approximately +2.1% above the issue price of ₹676. Grey market prices can shift before listing — treat this as an estimate only.
Is the GMP of Prasol Chemicals IPO increasing or decreasing?
The GMP of Prasol Chemicals IPO is currently stable. Track the day-wise GMP table above for the latest movement.
Explore Prasol Chemicals IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!